Vancouver, Canada

Bradford Gill

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Provincial Health Services Authority. Active years: 2022.


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bradford Gill - Innovator in Radiation Treatment Technology

Introduction

Bradford Gill is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of medical technology, particularly in the area of radiation treatment for breast cancer patients. His innovative approach aims to enhance patient care and improve treatment outcomes.

Latest Patents

Bradford Gill holds a patent for an "Apparatus for positioning a breast for radiation treatment." This invention provides a method and apparatus designed to decrease both acute and late skin toxicity for breast cancer patients undergoing radiation therapy. The technology enables better breast positioning during therapy, effectively eliminating skin folds and reducing the skin dose below the threshold required for the development of moist desquamation. This advancement has the potential to minimize the volume of normal tissue and organs at risk of being irradiated during a course of whole breast radiation therapy.

Career Highlights

Bradford Gill is associated with the Provincial Health Services Authority, where he applies his expertise to improve healthcare delivery. His work is instrumental in advancing treatment methodologies that prioritize patient safety and comfort.

Collaborations

Some of his coworkers include Christina Cumayas and Robin Coope, who contribute to the collaborative efforts in enhancing medical technologies.

Conclusion

Bradford Gill's innovative work in radiation treatment technology exemplifies the impact of inventions on patient care. His contributions are paving the way for improved outcomes in breast cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…